about
Strategies for managing sexual dysfunction induced by antidepressant medicationStrategies for managing sexual dysfunction induced by antidepressant medicationSelective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewVenlafaxine for major depressionRisk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort studyAntidepressants and suicide: risk-benefit conundrumsThe utilization of antidepressants--a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994Consent for the use of personal medical data in research.Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.Depression in adults: drug and physical treatments.Suicide in the course of the treatment of depression.Antidepressants and Suicide Risk: A Comprehensive OverviewAntidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.Selective serotonin re-uptake inhibitors for children and adolescents.Which antidepressant? A commentary from general practice on evidence-based medicine and health economics.Potential for suicide prevention in primary care? An analysis of factors associated with suicide.Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.The psychopharmacologic treatment of depression and anxiety in the context of chronic pain.Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.Rate of suicide in patients taking montelukast.Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.Diagnosis and treatment of major depression 2007.The electronic patient record in primary care--regression or progression? A cross sectional studyDrug use and pulmonary death rates in increasingly symptomatic asthma patients in the UKAntidepressants and suicide: what is the balance of benefit and harm.Death and dependence: current controversies over the selective serotonin reuptake inhibitors.A study of the relation of exposure to quinolones and suicidal behaviour.Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression.Validation of suicide and self-harm records in the Clinical Practice Research Datalink.Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studiesDo SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.Serial Monitoring of Lead aVR in Patients with Prolonged Unconsciousness Following Tricyclic Antidepressant Overdose.Disopyramide and mianserin intoxication: a unique fatal case--review of the literature.Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011.Practitioner review: the pharmacotherapy of adolescent depression.Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.Long term pharmacotherapy of depression. Can reduce relapses and recurrences in major depression.Antidepressants and suicide. Study analyses were flawed.
P2860
Q24202675-8F1FDFCC-9F31-4CF6-BD43-A8AFC0EE56A3Q24245847-EB8621C5-F4FD-4407-B0E9-BEC2E548752BQ24556640-ADFECF86-A061-489D-9FEF-C0BE54241D63Q24678849-7D1C2773-AF95-4143-A5F7-95C56D19B967Q24678875-676CCDFC-F884-46A9-B78D-272F1E360D8CQ24682133-35F61590-62C4-4084-A768-C32DB3646922Q28247414-1AA3A026-BB25-47D1-929A-E5541D7B67FDQ31050200-667FB444-5D6C-4A5B-BF56-EECDAED4AD50Q33365152-371DB47A-A3B8-4C5D-8D31-9A84B04520F9Q33448181-089E5312-7CA3-4D3B-97C7-BE2CA250BDD2Q33604204-93780A47-4890-4278-87C6-E23308A318C6Q33664712-6A63AC82-DBBF-45D9-ACB6-12D0268DA550Q33853140-A1A8617E-C3DC-461D-BDB6-544F14947D26Q34120056-225B9B67-197E-4601-9EF3-C7D8FBFD393AQ34214135-9BEE2192-7D71-429D-A7FF-12171DD7F68FQ34216024-AA4EA431-86F5-41EA-8801-D5D435B46611Q34216987-9BA00909-B802-4652-BAA1-558DD928E228Q34466155-292CA93F-0C5F-43B1-BDB9-B50B3D58E0EAQ34586954-3051D5F9-E524-4610-8C33-53AB4CF28457Q34603635-8CE53854-5C24-4CD7-B1E1-934C69E01B0CQ34622073-A4BAFF69-778B-4AD3-BF80-FBE42FC75B65Q34675310-DA1F3ADB-1DDC-44AF-B263-4AA169F72B10Q35107948-07202353-D2B4-43C7-90E2-C24EDD41D909Q35563710-8898DACE-2D00-4B80-84B9-855D20993048Q35615293-7808970D-2131-4190-88FE-A7D6D977115DQ35660695-ED225105-E157-40C3-A556-4CB7D7457DBAQ35803102-F6D4B1C7-7EEE-46B4-A481-6109D2783620Q35827193-CBCDCB8B-6E61-483D-B585-A2277A8C14D1Q36637677-206A242D-EECD-4077-8012-925990CB2CABQ36988030-B862D557-7090-4611-9EE6-8C7B07FFA983Q37071328-C5105054-5CAC-4C32-B42E-E0668EAF454AQ37230978-E47779C1-D947-4002-B729-4178141F9BD9Q37483913-3C07B589-7C1C-4E7C-8352-52E869C46C72Q38185683-CA8647F1-EA13-4DED-8B20-FD19EA912921Q38608635-04FF07D2-AD61-4EA0-9F65-A691C9935E2EQ41639222-DE20040F-BCFD-4160-9E5F-F59B01FA745BQ41887016-0A18A21B-1E9F-4691-96F1-3E1900B47FFCQ42606458-375BCF1D-352E-4922-880C-2B323670A23BQ42756612-794EAE76-B59F-4A91-84AE-62F1F4602F63Q42867988-E33DED9B-9852-4D4A-95EF-2D8718712176
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Antidepressants and suicide
@en
type
label
Antidepressants and suicide
@en
prefLabel
Antidepressants and suicide
@en
P2860
P356
P1433
P1476
Antidepressants and suicide.
@en
P2093
P2860
P304
P356
10.1136/BMJ.310.6974.215
P407
P50
P577
1995-01-01T00:00:00Z